HOUSTON, TX / ACCESSWIRE / July 23, 2024 / Mann Eye Institute, a leader in ophthalmologic care, proudly announces the integration of the ZEISS miCOR 700 technology into their cataract surgery procedures. This innovative lens extraction device represents the future of cataract treatment, offering enhanced precision, safety, and efficiency.
The ZEISS miCOR 700 revolutionizes lens extraction by eliminating the need for ultrasound. Unlike traditional cataract surgery methods, miCOR uses an asymmetric movement of the cutter tube, reducing thermal energy and minimizing the risk of ocular tissue damage. This gentle approach to crystalline lens extraction increases the chances of a safer and more comfortable patient experience. Additionally, the miCOR 700 offers a streamlined OR setup with a completely disposable fluidics system, providing a sterile environment and saving time throughout the surgical day.
Dr. Hacopian, a leading ophthalmologist at Mann Eye Institute, expressed enthusiasm about the new technology: “We are thrilled to bring the ZEISS miCOR 700 to our patients. This cutting-edge device allows us to perform cataract surgeries with unparalleled precision and safety. Our patients will benefit from a gentler procedure and faster recovery times.”
Mann Eye Institute remains committed to providing the highest standard of eye care through the adoption of advanced technologies. The introduction of the ZEISS miCOR 700 aligns with the institute’s mission to enhance patient outcomes and comfort.
For more information about the ZEISS miCOR 700 and to schedule a consultation, please visit Mann Eye Institute or contact us at 844-969-2020.
About Mann Eye Institute: Mann Eye Institute has been at the forefront of vision correction for over 45 years, offering a wide range of services, from comprehensive eye exams to advanced surgical procedures. The institute is dedicated to improving the quality of life for its patients through innovative treatments and personalized care.
Contact Information
Dina Owens
Communications Team
info@manneye.com
SOURCE: Mann Eye Institute
View the original press release on newswire.com.
HeartBeam system was recently cleared by US Food and Drug Administration (FDA) for comprehensive arrhythmia…
ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused…
This generous grant will directly benefit the NCCS's Beyond the Cure Ambassador Scholarship Program, which…
Medical Co-working space challenges broken healthcare system. HOUSTON, TEXAS / ACCESSWIRE / December 23, 2024…
SAN DIEGO, CALIFORNIA / ACCESSWIRE / December 23, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce"…
MIAMI, FL / ACCESSWIRE / December 23, 2024 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO), or the…
